Cell therapy manufacturing company building automated Smart Factories.
| Date | Round | Amount |
|---|---|---|
| Jun 2026 | Series D Plus ARK Invest added $20M to Cellares' Series D, bringing the round to $277M alongside BlackRock, Eclipse, T. Rowe Price and others, to scale cell-therapy Smart Factories. | $277M |